endolysin has been researched along with daptomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, K; Bisdas, T; Herten, M; Idelevich, EA; Osada, N; Scherzinger, AS; Sielker, S; Torsello, GB | 1 |
| Becker, K; Idelevich, EA; Knaack, D; Kriegeskorte, A; Molinaro, S; Peters, G; Schleimer, N | 1 |
2 other study(ies) available for endolysin and daptomycin
| Article | Year |
|---|---|
Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells.
Topics: Anti-Bacterial Agents; Cell Survival; Daptomycin; Endopeptidases; Endothelial Cells; Fibroblasts; Humans; Microbial Sensitivity Tests; Muscle, Smooth, Vascular; Rifampin; Vancomycin; Vascular Grafting | 2017 |
Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis.
Topics: Anti-Bacterial Agents; Daptomycin; Endopeptidases; Microbial Sensitivity Tests; Microbial Viability; Mupirocin; Recombinant Proteins; Staphylococcus aureus; Staphylococcus Phages | 2019 |